HEALTH

• The head of Africa's Centres for Disease Control and Prevention warned on Tuesday, June 16, that the current Ebola outbreak in Congo could become the worst on record. • A critical failure in containment has occurred, with tens of thousands of individuals who were in contact with infected patients remaining untraced. • This lack of contact tracing significantly increases the risk of uncontrolled community transmission and a larger-scale health crisis.

• Declining vaccination rates have led to a resurgence of measles, prompting biotech companies and researchers to seek pharmaceutical treatments for the disease. • Dr. Plemper of Georgia State University is working on a drug that could potentially be used off-label to treat measles patients if approved. • Experts, including Dr. Mina, emphasize that while new treatments are necessary to prevent deaths, widespread vaccination remains the only effective way to stop the outbreaks.

• Millions of Americans remain interested in GLP-1 medications for weight loss and health management but have not yet begun treatment. • According to Ondra Health, the primary obstacle for these potential patients has shifted from a lack of awareness or access to a lack of trust in the medications. • This trend is significant as clinical evidence supporting the efficacy of GLP-1 drugs continues to grow, yet psychological barriers persist.

• New data highlight how structural racism, policy, and pricing continue to drive racial and ethnic disparities in U.S. healthcare access and outcomes. • Sickle cell disease (SCD), which primarily affects non-Hispanic Black or African American individuals, remains a critical focus as it can shorten life expectancy by approximately 20 years. • Treatment options have evolved from the 1994 approval of hydroxyurea to include newer medications like voxelotor and crizanlizumab, culminating in the 2023 approval of gene therapies.

• A new study has revealed the neurological process by which the brain updates predictions and adapts to change, specifically regarding how it distinguishes between internal and external sounds. • Separate research has identified a gut-based mechanism that links sleep apnea to an increased risk of heart disease. • These findings are significant as they provide deeper insights into brain plasticity and uncover a potential biological pathway for protecting the heart from sleep-related breathing disorders.

• The U.S. federal government has implemented funding cuts and personnel downsizing within biopreparedness programs dedicated to high-consequence infectious diseases (HCID). • These reductions occur while the U.S. is actively managing threats from Ebola and a Hantavirus cluster associated with cruise ship travel. • Although existing infrastructure and protocols are currently handling these outbreaks, experts warn that diminished resources will leave the nation less prepared for future pandemics.

• Experts are calling for public investment to develop a vaccine for the Bundibugyo ebolavirus, noting that previous Zaire ebolavirus vaccines required billions of dollars and decades of research. • The proposed strategy involves initial laboratory testing, small-scale clinical trials to ensure safety and antibody response, and the pre-emptive manufacturing of doses. • This proactive approach is critical because it allows health officials to have vaccines ready for immediate deployment during the next outbreak.

• The Middle East and North Africa (MENA) region is experiencing a growth in clinical trials research, specifically focusing on genetic disorders. • The Catalogue for Transmission Genetics in Arabs (CTGA) is being utilized to track and list genetic conditions prevalent across the Arab world. • Current research efforts are specifically targeting Gaucher's disease, an orphan-designated condition causing fatty substance accumulation in the liver, spleen, and central nervous system.

• The FDA has issued multiregional guidance to optimize global hematology trials, emphasizing the need for better communication between regulators, trial designers, and investigators. • Key requirements include maintaining balanced regional enrollment and implementing rigorous control arms that remain relevant to the U.S. healthcare landscape. • These measures are critical to ensure that new hematology drugs successfully navigate the path to regulatory approval, reimbursement, and widespread clinical uptake.

• Scientists are launching clinical trials for several drugs that showed promise in preliminary studies to combat a widening Ebola outbreak. • The trials are focusing on treatments for the virus currently affecting regions such as the Democratic Republic of Congo, including the town of Mongbwalu. • This effort is critical as health workers struggle to contain the spread of the virus and manage patients suspected of having the Bundibugyo strain.

• The 2026 World Cup is projected to be the largest in history, creating a high-risk environment for the transmission of infectious diseases due to massive global crowds. • Health experts warn that pathogens such as measles and norovirus could spread rapidly among fans and athletes traveling across host cities. • This risk is significant because large-scale international gatherings facilitate the movement of viruses across borders, potentially leading to localized outbreaks.

• Philips CEO Roy Jakobs appeared on ‘Varney & Co.’ to discuss how AI integration is improving patient care and mitigating critical staffing shortages for clinicians. • Regulators issued a recall for nearly 13,000 toddler tower stools across three different brands following reports of collapsing and tipping that caused dozens of injuries. • Trulieve CEO Kim Rivers detailed the implications of the Trump administration's decision to reclassify state-licensed medical cannabis from Schedule 1 to Schedule 3.

• Medical experts highlight that misoprostol, typically used in a two-drug abortion protocol, is safe and effective as a standalone option for medication abortions. • The Supreme Court addressed telemedicine access to mifepristone on May 4, 2026, reflecting ongoing legal battles over drug accessibility. • As of March 3, 2025, two fully approved drugs are available to slow Alzheimer's disease progression, reducing mental decline by over 25% in certain patient groups.

• A recent health equity roundup highlights critical gaps in US healthcare, noting that nonmetropolitan areas have 44.4% fewer patient-facing workers per 10,000 residents than urban centers. • Data from the 2019-2023 American Community Survey reveals a stark imbalance: rural areas house 13.8% of the population but only 8.4% of the healthcare workforce. • Experts emphasize that meeting the WHO goal of reducing hepatitis B mortality by 65% requires increased investment in vaccinations, screenings, and stigma reduction.

• A federal grand jury in the Southern District of Florida charged a medical doctor and two staff members for falsifying data during clinical drug trials. • Starting around 2019, the defendants allegedly fabricated testing records to falsely indicate that human subjects had taken medications and undergone required protocol testing. • The scheme targeted trials sponsored by a pharmaceutical development company intended to evaluate the safety and efficacy of new drugs for FDA approval.

• A World Health Organization (WHO) expert warned on Friday, June 12, that "blind spots" in the Democratic Republic of Congo may be hiding the true scale of the current Ebola outbreak. • The expert suggests that the spread of the deadly disease could be significantly wider than what is currently reflected in official estimates. • This gap in data is critical because it hinders the ability of health agencies to accurately track and contain the virus's transmission.

• On June 2, 2026, the CDC issued a travel alert for seven Sub-Saharan African countries—Chad, Guinea, Niger, Nigeria, Mali, Mauritania, and Somalia—following a severe diphtheria outbreak. • The alert follows alarming 2025 WHO data documenting 20,412 suspected cases and 1,252 deaths across Africa, highlighting a critical public health crisis. • The warning serves as a vital notice for travelers and unvaccinated Americans to ensure proper immunization before visiting the affected regions.

• The June 12, 2026, public health update reports on a current outbreak of the Bundibugyo virus disease and the introduction of new clinical guidelines for CKM syndrome. • The report covers critical developments across infectious disease surveillance, prevention strategies, chronic disease management, and emerging medical technologies. • These updates are vital for healthcare providers and policymakers to implement the latest clinical standards and contain the viral spread.